🇺🇸 FDA
Patent

US 12110344

Antibodies that bind to cis and uses thereof

granted A61KA61K2039/505A61K2039/54

Quick answer

US patent 12110344 (Antibodies that bind to cis and uses thereof) held by DIANTHUS THERAPEUTICS OPCO, INC. expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DIANTHUS THERAPEUTICS OPCO, INC.
Grant date
Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K39/00